Updated On: 11 February, 2022 08:16 AM IST | Washington | Agencies
USFDA is considering authorising Pfizer/BioNTech vaccine; roll out expected as soon as February 21

A child is comforted by her mother as she receives her first dose of COVID vaccine, in Michigan. File pic/AFP
The US government is planning to roll out Covid-19 shots for children under the age of 5 as soon as February 21, according to a document from the US Centres for Disease Control and Prevention. The US Food and Drug Administration (FDA) is considering authorising the use of the Pfizer and BioNTech vaccine in the age group, even though it did not meet a key target in a clinical trial of two- to four-year-olds.
Outside advisers to the FDA are scheduled to meet on February 15 to discuss whether to recommend the regulator to authorise the vaccine. According to the CDC document, the US government is planning to ship an initial 10 million doses of the Pfizer/BioNTech vaccine to states and other entities before the end of February, should the FDA authorise their use. There are about 18 million children aged between 6 months to 4 years in the US, the CDC said.